President Joe Biden on Monday invoked a Cold War-era measure to boost investment in U.S. manufacturing of medicines and medical supplies that he has deemed important for national defense.
Novo Nordisk will ration starter kits of Ozempic in Europe and reduce supplies of another diabetes drug, Victoza, to prioritise producing Ozempic, which has seen a surge in demand from people using it to lose weight.
Obesity drug maker Novo Nordisk will spend $6 billion to boost production in Denmark, although its CEO warned the industry was far from being able to meet global demand.
A decades-old federal program that offers doctors incentives to practice in disadvantaged communities has had little effect on physician density or patient mortality.